CYSTEAMINE BITARTRATE
| Brand name | PROCYSBI |
|---|---|
| Active ingredient | CYSTEAMINE BITARTRATE |
| Strength | EQ 25MG BASE |
| Dosage form | CAPSULE, DELAYED RELEASE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | April 2013 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 10905662*PED | February 2037 | — |
| 10328037*PED | February 2037 | — |
| 10548859*PED | February 2037 | — |
| 10143665*PED | February 2037 | — |
| 10143665 | August 2036 | use U-1399 |
| 10905662 | August 2036 | use U-1399 |
| 10328037 | August 2036 | use U-1399 |
| 10548859 | August 2036 | use U-1399 |
| 9233077*PED | December 2034 | — |
| 9173851*PED | December 2034 | — |
| 9173851 | June 2034 | product |
| 9233077 | June 2034 | product |
| 8026284*PED | March 2028 | — |
| 8026284 | September 2027 | use U-1399 |
| 9192590*PED | July 2027 | — |
| 9925156*PED | July 2027 | — |
| 9925157*PED | July 2027 | — |
| 9925158*PED | July 2027 | — |
| 9198882*PED | July 2027 | — |
| 9925156 | January 2027 | substance, product |
| 9925157 | January 2027 | substance, product |
| 9925158 | January 2027 | substance, product |
| 9198882 | January 2027 | use U-1399 |
| 9192590 | January 2027 | use U-1399 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.